IL-6 Blockade Disappoints in Early COVID-19

(MedPage Today) -- Tocilizumab (Actemra) didn't show clear evidence of efficacy against COVID-19 relatively early in the disease course in a slew of data from randomized trials and observational studies.
The monoclonal antibody against inflammatory...